Pharma & Healthcare
Global Pirfenidone Drugs Market Research Report 2026
- Feb 24, 26
- ID: 721031
- Pages: 111
- Figures: 117
- Views: 1
This report delivers a comprehensive overview of the global Pirfenidone Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pirfenidone Drugs. The Pirfenidone Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pirfenidone Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pirfenidone Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Accord Healthcare
Amneal Pharmaceuticals
Sandoz
ScieGen Pharmaceuticals
Gyre Pharmaceuticals
Apotex
Teva
Kawin
Segment by Type
Capsules
Tablets
by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pirfenidone Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pirfenidone Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Pirfenidone Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pirfenidone Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Accord Healthcare
Amneal Pharmaceuticals
Sandoz
ScieGen Pharmaceuticals
Gyre Pharmaceuticals
Apotex
Teva
Kawin
Segment by Type
Capsules
Tablets
by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pirfenidone Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pirfenidone Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Pirfenidone Drugs Market Overview
1.1 Product Definition
1.2 Pirfenidone Drugs by Type
1.2.1 Global Pirfenidone Drugs Market Value by Type: 2025 vs 2032
1.2.2 Capsules
1.2.3 Tablets
1.3 Pirfenidone Drugs by Application
1.3.1 Global Pirfenidone Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Pirfenidone Drugs Market Size Estimates and Forecasts
1.4.1 Global Pirfenidone Drugs Revenue 2021–2032
1.4.2 Global Pirfenidone Drugs Sales 2021–2032
1.4.3 Global Pirfenidone Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pirfenidone Drugs Market Competition by Manufacturers
2.1 Global Pirfenidone Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pirfenidone Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pirfenidone Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pirfenidone Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pirfenidone Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pirfenidone Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Pirfenidone Drugs, Date of Entry into the Industry
2.8 Global Pirfenidone Drugs Market Competitive Situation and Trends
2.8.1 Global Pirfenidone Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pirfenidone Drugs Players Market Share by Revenue
2.8.3 Global Pirfenidone Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pirfenidone Drugs Market Scenario by Region
3.1 Global Pirfenidone Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pirfenidone Drugs Sales by Region: 2021–2032
3.2.1 Global Pirfenidone Drugs Sales by Region: 2021–2026
3.2.2 Global Pirfenidone Drugs Sales by Region: 2027–2032
3.3 Global Pirfenidone Drugs Revenue by Region: 2021–2032
3.3.1 Global Pirfenidone Drugs Revenue by Region: 2021–2026
3.3.2 Global Pirfenidone Drugs Revenue by Region: 2027–2032
3.4 North America Pirfenidone Drugs Market Facts & Figures by Country
3.4.1 North America Pirfenidone Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pirfenidone Drugs Sales by Country (2021–2032)
3.4.3 North America Pirfenidone Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pirfenidone Drugs Market Facts & Figures by Country
3.5.1 Europe Pirfenidone Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pirfenidone Drugs Sales by Country (2021–2032)
3.5.3 Europe Pirfenidone Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pirfenidone Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Pirfenidone Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pirfenidone Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Pirfenidone Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pirfenidone Drugs Market Facts & Figures by Country
3.7.1 Latin America Pirfenidone Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pirfenidone Drugs Sales by Country (2021–2032)
3.7.3 Latin America Pirfenidone Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pirfenidone Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pirfenidone Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pirfenidone Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pirfenidone Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pirfenidone Drugs Sales by Type (2021–2032)
4.1.1 Global Pirfenidone Drugs Sales by Type (2021–2026)
4.1.2 Global Pirfenidone Drugs Sales by Type (2027–2032)
4.1.3 Global Pirfenidone Drugs Sales Market Share by Type (2021–2032)
4.2 Global Pirfenidone Drugs Revenue by Type (2021–2032)
4.2.1 Global Pirfenidone Drugs Revenue by Type (2021–2026)
4.2.2 Global Pirfenidone Drugs Revenue by Type (2027–2032)
4.2.3 Global Pirfenidone Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Pirfenidone Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pirfenidone Drugs Sales by Application (2021–2032)
5.1.1 Global Pirfenidone Drugs Sales by Application (2021–2026)
5.1.2 Global Pirfenidone Drugs Sales by Application (2027–2032)
5.1.3 Global Pirfenidone Drugs Sales Market Share by Application (2021–2032)
5.2 Global Pirfenidone Drugs Revenue by Application (2021–2032)
5.2.1 Global Pirfenidone Drugs Revenue by Application (2021–2026)
5.2.2 Global Pirfenidone Drugs Revenue by Application (2027–2032)
5.2.3 Global Pirfenidone Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Pirfenidone Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Pirfenidone Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Accord Healthcare
6.2.1 Accord Healthcare Company Information
6.2.2 Accord Healthcare Description and Business Overview
6.2.3 Accord Healthcare Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Accord Healthcare Pirfenidone Drugs Product Portfolio
6.2.5 Accord Healthcare Recent Developments/Updates
6.3 Amneal Pharmaceuticals
6.3.1 Amneal Pharmaceuticals Company Information
6.3.2 Amneal Pharmaceuticals Description and Business Overview
6.3.3 Amneal Pharmaceuticals Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Amneal Pharmaceuticals Pirfenidone Drugs Product Portfolio
6.3.5 Amneal Pharmaceuticals Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sandoz Pirfenidone Drugs Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 ScieGen Pharmaceuticals
6.5.1 ScieGen Pharmaceuticals Company Information
6.5.2 ScieGen Pharmaceuticals Description and Business Overview
6.5.3 ScieGen Pharmaceuticals Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 ScieGen Pharmaceuticals Pirfenidone Drugs Product Portfolio
6.5.5 ScieGen Pharmaceuticals Recent Developments/Updates
6.6 Gyre Pharmaceuticals
6.6.1 Gyre Pharmaceuticals Company Information
6.6.2 Gyre Pharmaceuticals Description and Business Overview
6.6.3 Gyre Pharmaceuticals Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Gyre Pharmaceuticals Pirfenidone Drugs Product Portfolio
6.6.5 Gyre Pharmaceuticals Recent Developments/Updates
6.7 Apotex
6.7.1 Apotex Company Information
6.7.2 Apotex Description and Business Overview
6.7.3 Apotex Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Apotex Pirfenidone Drugs Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Teva
6.8.1 Teva Company Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Teva Pirfenidone Drugs Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Kawin
6.9.1 Kawin Company Information
6.9.2 Kawin Description and Business Overview
6.9.3 Kawin Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Kawin Pirfenidone Drugs Product Portfolio
6.9.5 Kawin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pirfenidone Drugs Industry Chain Analysis
7.2 Pirfenidone Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pirfenidone Drugs Production Mode & Process Analysis
7.4 Pirfenidone Drugs Sales and Marketing
7.4.1 Pirfenidone Drugs Sales Channels
7.4.2 Pirfenidone Drugs Distributors
7.5 Pirfenidone Drugs Customer Analysis
8 Pirfenidone Drugs Market Dynamics
8.1 Pirfenidone Drugs Industry Trends
8.2 Pirfenidone Drugs Market Drivers
8.3 Pirfenidone Drugs Market Challenges
8.4 Pirfenidone Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pirfenidone Drugs by Type
1.2.1 Global Pirfenidone Drugs Market Value by Type: 2025 vs 2032
1.2.2 Capsules
1.2.3 Tablets
1.3 Pirfenidone Drugs by Application
1.3.1 Global Pirfenidone Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Pirfenidone Drugs Market Size Estimates and Forecasts
1.4.1 Global Pirfenidone Drugs Revenue 2021–2032
1.4.2 Global Pirfenidone Drugs Sales 2021–2032
1.4.3 Global Pirfenidone Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pirfenidone Drugs Market Competition by Manufacturers
2.1 Global Pirfenidone Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pirfenidone Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pirfenidone Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pirfenidone Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pirfenidone Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pirfenidone Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Pirfenidone Drugs, Date of Entry into the Industry
2.8 Global Pirfenidone Drugs Market Competitive Situation and Trends
2.8.1 Global Pirfenidone Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pirfenidone Drugs Players Market Share by Revenue
2.8.3 Global Pirfenidone Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pirfenidone Drugs Market Scenario by Region
3.1 Global Pirfenidone Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pirfenidone Drugs Sales by Region: 2021–2032
3.2.1 Global Pirfenidone Drugs Sales by Region: 2021–2026
3.2.2 Global Pirfenidone Drugs Sales by Region: 2027–2032
3.3 Global Pirfenidone Drugs Revenue by Region: 2021–2032
3.3.1 Global Pirfenidone Drugs Revenue by Region: 2021–2026
3.3.2 Global Pirfenidone Drugs Revenue by Region: 2027–2032
3.4 North America Pirfenidone Drugs Market Facts & Figures by Country
3.4.1 North America Pirfenidone Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pirfenidone Drugs Sales by Country (2021–2032)
3.4.3 North America Pirfenidone Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pirfenidone Drugs Market Facts & Figures by Country
3.5.1 Europe Pirfenidone Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pirfenidone Drugs Sales by Country (2021–2032)
3.5.3 Europe Pirfenidone Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pirfenidone Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Pirfenidone Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pirfenidone Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Pirfenidone Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pirfenidone Drugs Market Facts & Figures by Country
3.7.1 Latin America Pirfenidone Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pirfenidone Drugs Sales by Country (2021–2032)
3.7.3 Latin America Pirfenidone Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pirfenidone Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pirfenidone Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pirfenidone Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pirfenidone Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pirfenidone Drugs Sales by Type (2021–2032)
4.1.1 Global Pirfenidone Drugs Sales by Type (2021–2026)
4.1.2 Global Pirfenidone Drugs Sales by Type (2027–2032)
4.1.3 Global Pirfenidone Drugs Sales Market Share by Type (2021–2032)
4.2 Global Pirfenidone Drugs Revenue by Type (2021–2032)
4.2.1 Global Pirfenidone Drugs Revenue by Type (2021–2026)
4.2.2 Global Pirfenidone Drugs Revenue by Type (2027–2032)
4.2.3 Global Pirfenidone Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Pirfenidone Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pirfenidone Drugs Sales by Application (2021–2032)
5.1.1 Global Pirfenidone Drugs Sales by Application (2021–2026)
5.1.2 Global Pirfenidone Drugs Sales by Application (2027–2032)
5.1.3 Global Pirfenidone Drugs Sales Market Share by Application (2021–2032)
5.2 Global Pirfenidone Drugs Revenue by Application (2021–2032)
5.2.1 Global Pirfenidone Drugs Revenue by Application (2021–2026)
5.2.2 Global Pirfenidone Drugs Revenue by Application (2027–2032)
5.2.3 Global Pirfenidone Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Pirfenidone Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Pirfenidone Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Accord Healthcare
6.2.1 Accord Healthcare Company Information
6.2.2 Accord Healthcare Description and Business Overview
6.2.3 Accord Healthcare Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Accord Healthcare Pirfenidone Drugs Product Portfolio
6.2.5 Accord Healthcare Recent Developments/Updates
6.3 Amneal Pharmaceuticals
6.3.1 Amneal Pharmaceuticals Company Information
6.3.2 Amneal Pharmaceuticals Description and Business Overview
6.3.3 Amneal Pharmaceuticals Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Amneal Pharmaceuticals Pirfenidone Drugs Product Portfolio
6.3.5 Amneal Pharmaceuticals Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sandoz Pirfenidone Drugs Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 ScieGen Pharmaceuticals
6.5.1 ScieGen Pharmaceuticals Company Information
6.5.2 ScieGen Pharmaceuticals Description and Business Overview
6.5.3 ScieGen Pharmaceuticals Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 ScieGen Pharmaceuticals Pirfenidone Drugs Product Portfolio
6.5.5 ScieGen Pharmaceuticals Recent Developments/Updates
6.6 Gyre Pharmaceuticals
6.6.1 Gyre Pharmaceuticals Company Information
6.6.2 Gyre Pharmaceuticals Description and Business Overview
6.6.3 Gyre Pharmaceuticals Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Gyre Pharmaceuticals Pirfenidone Drugs Product Portfolio
6.6.5 Gyre Pharmaceuticals Recent Developments/Updates
6.7 Apotex
6.7.1 Apotex Company Information
6.7.2 Apotex Description and Business Overview
6.7.3 Apotex Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Apotex Pirfenidone Drugs Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Teva
6.8.1 Teva Company Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Teva Pirfenidone Drugs Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Kawin
6.9.1 Kawin Company Information
6.9.2 Kawin Description and Business Overview
6.9.3 Kawin Pirfenidone Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Kawin Pirfenidone Drugs Product Portfolio
6.9.5 Kawin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pirfenidone Drugs Industry Chain Analysis
7.2 Pirfenidone Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pirfenidone Drugs Production Mode & Process Analysis
7.4 Pirfenidone Drugs Sales and Marketing
7.4.1 Pirfenidone Drugs Sales Channels
7.4.2 Pirfenidone Drugs Distributors
7.5 Pirfenidone Drugs Customer Analysis
8 Pirfenidone Drugs Market Dynamics
8.1 Pirfenidone Drugs Industry Trends
8.2 Pirfenidone Drugs Market Drivers
8.3 Pirfenidone Drugs Market Challenges
8.4 Pirfenidone Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pirfenidone Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pirfenidone Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pirfenidone Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pirfenidone Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pirfenidone Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pirfenidone Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pirfenidone Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pirfenidone Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pirfenidone Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pirfenidone Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pirfenidone Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Pirfenidone Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pirfenidone Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pirfenidone Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pirfenidone Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pirfenidone Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Pirfenidone Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Pirfenidone Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Pirfenidone Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Pirfenidone Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pirfenidone Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Pirfenidone Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pirfenidone Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Pirfenidone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pirfenidone Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Pirfenidone Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Pirfenidone Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pirfenidone Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pirfenidone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pirfenidone Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Pirfenidone Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Pirfenidone Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pirfenidone Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pirfenidone Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pirfenidone Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pirfenidone Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pirfenidone Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pirfenidone Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pirfenidone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pirfenidone Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Pirfenidone Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Pirfenidone Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pirfenidone Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pirfenidone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pirfenidone Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pirfenidone Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pirfenidone Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pirfenidone Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pirfenidone Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Pirfenidone Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Pirfenidone Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Pirfenidone Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Pirfenidone Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pirfenidone Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pirfenidone Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Pirfenidone Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Pirfenidone Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pirfenidone Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pirfenidone Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Pirfenidone Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Pirfenidone Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Pirfenidone Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Pirfenidone Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pirfenidone Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pirfenidone Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Pirfenidone Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Pirfenidone Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pirfenidone Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Roche Pirfenidone Drugs Product
Table 74. Roche Recent Developments/Updates
Table 75. Accord Healthcare Company Information
Table 76. Accord Healthcare Description and Business Overview
Table 77. Accord Healthcare Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Accord Healthcare Pirfenidone Drugs Product
Table 79. Accord Healthcare Recent Developments/Updates
Table 80. Amneal Pharmaceuticals Company Information
Table 81. Amneal Pharmaceuticals Description and Business Overview
Table 82. Amneal Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Amneal Pharmaceuticals Pirfenidone Drugs Product
Table 84. Amneal Pharmaceuticals Recent Developments/Updates
Table 85. Sandoz Company Information
Table 86. Sandoz Description and Business Overview
Table 87. Sandoz Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sandoz Pirfenidone Drugs Product
Table 89. Sandoz Recent Developments/Updates
Table 90. ScieGen Pharmaceuticals Company Information
Table 91. ScieGen Pharmaceuticals Description and Business Overview
Table 92. ScieGen Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. ScieGen Pharmaceuticals Pirfenidone Drugs Product
Table 94. ScieGen Pharmaceuticals Recent Developments/Updates
Table 95. Gyre Pharmaceuticals Company Information
Table 96. Gyre Pharmaceuticals Description and Business Overview
Table 97. Gyre Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Gyre Pharmaceuticals Pirfenidone Drugs Product
Table 99. Gyre Pharmaceuticals Recent Developments/Updates
Table 100. Apotex Company Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Apotex Pirfenidone Drugs Product
Table 104. Apotex Recent Developments/Updates
Table 105. Teva Company Information
Table 106. Teva Description and Business Overview
Table 107. Teva Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Teva Pirfenidone Drugs Product
Table 109. Teva Recent Developments/Updates
Table 110. Kawin Company Information
Table 111. Kawin Description and Business Overview
Table 112. Kawin Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Kawin Pirfenidone Drugs Product
Table 114. Kawin Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Pirfenidone Drugs Distributors List
Table 118. Pirfenidone Drugs Customers List
Table 119. Pirfenidone Drugs Market Trends
Table 120. Pirfenidone Drugs Market Drivers
Table 121. Pirfenidone Drugs Market Challenges
Table 122. Pirfenidone Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pirfenidone Drugs
Figure 2. Global Pirfenidone Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pirfenidone Drugs Market Share by Type: 2025 & 2032
Figure 4. Capsules Product Picture
Figure 5. Tablets Product Picture
Figure 6. Global Pirfenidone Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Pirfenidone Drugs Market Share by Application: 2025 & 2032
Figure 8. Hospital and Clinic
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Pirfenidone Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Pirfenidone Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global Pirfenidone Drugs Sales (K Units), 2021–2032
Figure 14. Global Pirfenidone Drugs Average Price (US$/Unit), 2021–2032
Figure 15. Pirfenidone Drugs Report Years Considered
Figure 16. Pirfenidone Drugs Sales Share by Manufacturers in 2025
Figure 17. Global Pirfenidone Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Pirfenidone Drugs Players: Market Share by Revenue in Pirfenidone Drugs in 2025
Figure 19. Pirfenidone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Pirfenidone Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Pirfenidone Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America Pirfenidone Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Pirfenidone Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe Pirfenidone Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Pirfenidone Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Pirfenidone Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Pirfenidone Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Pirfenidone Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Pirfenidone Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Pirfenidone Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Pirfenidone Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Pirfenidone Drugs by Type (2021–2032)
Figure 54. Global Pirfenidone Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Pirfenidone Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Pirfenidone Drugs by Application (2021–2032)
Figure 57. Global Pirfenidone Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. Pirfenidone Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Pirfenidone Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pirfenidone Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pirfenidone Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pirfenidone Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pirfenidone Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pirfenidone Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pirfenidone Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pirfenidone Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pirfenidone Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pirfenidone Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pirfenidone Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Pirfenidone Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pirfenidone Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pirfenidone Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pirfenidone Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pirfenidone Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Pirfenidone Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Pirfenidone Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Pirfenidone Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Pirfenidone Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pirfenidone Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Pirfenidone Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pirfenidone Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Pirfenidone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pirfenidone Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Pirfenidone Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Pirfenidone Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pirfenidone Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pirfenidone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pirfenidone Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Pirfenidone Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Pirfenidone Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pirfenidone Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pirfenidone Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pirfenidone Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pirfenidone Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pirfenidone Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pirfenidone Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pirfenidone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pirfenidone Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Pirfenidone Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Pirfenidone Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pirfenidone Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pirfenidone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pirfenidone Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pirfenidone Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pirfenidone Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pirfenidone Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pirfenidone Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Pirfenidone Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Pirfenidone Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Pirfenidone Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Pirfenidone Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pirfenidone Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pirfenidone Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Pirfenidone Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Pirfenidone Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pirfenidone Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pirfenidone Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Pirfenidone Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Pirfenidone Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Pirfenidone Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Pirfenidone Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pirfenidone Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pirfenidone Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Pirfenidone Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Pirfenidone Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pirfenidone Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Roche Pirfenidone Drugs Product
Table 74. Roche Recent Developments/Updates
Table 75. Accord Healthcare Company Information
Table 76. Accord Healthcare Description and Business Overview
Table 77. Accord Healthcare Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Accord Healthcare Pirfenidone Drugs Product
Table 79. Accord Healthcare Recent Developments/Updates
Table 80. Amneal Pharmaceuticals Company Information
Table 81. Amneal Pharmaceuticals Description and Business Overview
Table 82. Amneal Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Amneal Pharmaceuticals Pirfenidone Drugs Product
Table 84. Amneal Pharmaceuticals Recent Developments/Updates
Table 85. Sandoz Company Information
Table 86. Sandoz Description and Business Overview
Table 87. Sandoz Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sandoz Pirfenidone Drugs Product
Table 89. Sandoz Recent Developments/Updates
Table 90. ScieGen Pharmaceuticals Company Information
Table 91. ScieGen Pharmaceuticals Description and Business Overview
Table 92. ScieGen Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. ScieGen Pharmaceuticals Pirfenidone Drugs Product
Table 94. ScieGen Pharmaceuticals Recent Developments/Updates
Table 95. Gyre Pharmaceuticals Company Information
Table 96. Gyre Pharmaceuticals Description and Business Overview
Table 97. Gyre Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Gyre Pharmaceuticals Pirfenidone Drugs Product
Table 99. Gyre Pharmaceuticals Recent Developments/Updates
Table 100. Apotex Company Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Apotex Pirfenidone Drugs Product
Table 104. Apotex Recent Developments/Updates
Table 105. Teva Company Information
Table 106. Teva Description and Business Overview
Table 107. Teva Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Teva Pirfenidone Drugs Product
Table 109. Teva Recent Developments/Updates
Table 110. Kawin Company Information
Table 111. Kawin Description and Business Overview
Table 112. Kawin Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Kawin Pirfenidone Drugs Product
Table 114. Kawin Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Pirfenidone Drugs Distributors List
Table 118. Pirfenidone Drugs Customers List
Table 119. Pirfenidone Drugs Market Trends
Table 120. Pirfenidone Drugs Market Drivers
Table 121. Pirfenidone Drugs Market Challenges
Table 122. Pirfenidone Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pirfenidone Drugs
Figure 2. Global Pirfenidone Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pirfenidone Drugs Market Share by Type: 2025 & 2032
Figure 4. Capsules Product Picture
Figure 5. Tablets Product Picture
Figure 6. Global Pirfenidone Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Pirfenidone Drugs Market Share by Application: 2025 & 2032
Figure 8. Hospital and Clinic
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Pirfenidone Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Pirfenidone Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global Pirfenidone Drugs Sales (K Units), 2021–2032
Figure 14. Global Pirfenidone Drugs Average Price (US$/Unit), 2021–2032
Figure 15. Pirfenidone Drugs Report Years Considered
Figure 16. Pirfenidone Drugs Sales Share by Manufacturers in 2025
Figure 17. Global Pirfenidone Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Pirfenidone Drugs Players: Market Share by Revenue in Pirfenidone Drugs in 2025
Figure 19. Pirfenidone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Pirfenidone Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Pirfenidone Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America Pirfenidone Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Pirfenidone Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe Pirfenidone Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Pirfenidone Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Pirfenidone Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Pirfenidone Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Pirfenidone Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Pirfenidone Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Pirfenidone Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Pirfenidone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Pirfenidone Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Pirfenidone Drugs by Type (2021–2032)
Figure 54. Global Pirfenidone Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Pirfenidone Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Pirfenidone Drugs by Application (2021–2032)
Figure 57. Global Pirfenidone Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. Pirfenidone Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232